New AI tool may help personalize multiple myeloma treatment

AI Summary

A new artificial intelligence tool has been developed to help personalize treatment for patients with multiple myeloma. The AI analyzes patient data to predict effectiveness of therapies including immunotherapy and stem cell transplantation.

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem cell transplantation.